Which anticoagulant is safest for frail elderly patients with nonvalvular A-fib?

J. Scott Earwood; Justin L. Wilkie; Jennifer L. Fernandez-Vasquez; Rebecca Mullen

doi:10.12788/jfp.0509

Which anticoagulant is safest for frail elderly patients with nonvalvular A-fib?

J. Scott Earwood, Justin L. Wilkie, Jennifer L. Fernandez-Vasquez, Rebecca Mullen

Research output: Contribution to journal › Article › peer-review

Abstract

In a retrospective study comparing direct oral anticoagulants vs warfarin in this population, apixaban's adverse event rate was lower regardless of frailty status.

Original language	English (US)
Pages (from-to)	407-409
Number of pages	3
Journal	Journal of Family Practice
Volume	71
Issue number	10
DOIs	https://doi.org/10.12788/jfp.0509
State	Published - 2022
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.12788/jfp.0509

Cite this

@article{3e5f16b1bd924703a9f4953df55e495c,

title = "Which anticoagulant is safest for frail elderly patients with nonvalvular A-fib?",

abstract = "In a retrospective study comparing direct oral anticoagulants vs warfarin in this population, apixaban's adverse event rate was lower regardless of frailty status.",

author = "Earwood, {J. Scott} and Wilkie, {Justin L.} and Fernandez-Vasquez, {Jennifer L.} and Rebecca Mullen",

year = "2022",

doi = "10.12788/jfp.0509",

language = "English (US)",

volume = "71",

pages = "407--409",

journal = "Journal of Family Practice",

issn = "0094-3509",